RE: Reporting Modeling Results

Hi James and Steve I too am astounded that James thinks academic studies should be considered in a more critical light than industry studies. Which reminded me of this little snippet from an abstracting journal earlier this week! "Funding source of clinical studies affects authors' interpretation of results The funding source of clinical studies affects authors' interpretation of results, an analysis of 504 studies examining the effects of inhaled corticosteroids suggests (Archives of Internal Medicine 2007:167:2047). Manufacturer-funded trials are less likely to identify adverse effects of inhaled cortico-steroids than studies without pharmaceutical company funding, a finding partly explained by differences in trial design. In addition, authors of manufacturer-funded trials are less likely to conclude that statistically significant adverse effects are clinically important than authors of non-pharmaceutical-funded studies, researchers found" Cheers Carl Carl Kirkpatrick BPharm(Hons) PhD MPS School of Pharmacy University of Queensland St Lucia 4073 Brisbane, Australia Phone: +617 33653227 Fax: +617 33651688 URL: http://www.uq.edu.au/pharmacy/ckirkpatrick/kirkpatrick.htm "Doing things the way we always do them isn't the answer." Richard Soley University Provider Number: 00025B